# SRI Krishna Pharmaceuticals Ltd - Unit I - Inspection Records

Source: https://www.keypedia.com/companies/sri-krishna-pharmaceuticals-ltd-unit-i/a8609781-dc13-4ad6-9bb3-047ead2bf151

> Inspection records and compliance data for SRI Krishna Pharmaceuticals Ltd - Unit I in Hyderabad, None. Access full analysis and detailed observations.

---

## Details

- Name: SRI Krishna Pharmaceuticals Ltd - Unit I
- FEI Number: 3003723117
- City: Hyderabad
- State: None
- Country Name: India
- Address Line 1: C-4 Industrial Area, Uppal Khalsa, Medchal-Malkajgiri
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [483 - SRI Krishna Pharmaceuticals Ltd - Unit I - 2025-04-18](https://www.keypedia.com/records/483/sri-krishna-pharmaceuticals-ltd-unit-i/acb7723a-121f-4a23-a724-9e6969aa8323) — source: FDA, date: April 18, 2025
- [FDA Inspection 1271116 - SRI Krishna Pharmaceuticals Ltd - Unit I - 2025-04-18](https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-ltd-unit-i/0e1bf9b9-cc93-4e79-a050-0f75cf3e14a8) — source: FDA, date: April 18, 2025
- [FDA Inspection 1271116 - SRI Krishna Pharmaceuticals Ltd - Unit I - 2025-04-18](https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-ltd-unit-i/1138a22d-e3ce-493a-8a5d-3f0d2c38a39c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 18, 2025
- [483 - SRI Krishna Pharmaceuticals Ltd - Unit I - 2025-04-14](https://www.keypedia.com/records/483/sri-krishna-pharmaceuticals-ltd-unit-i/28922a80-78c4-4467-9bc7-cca018289876) — source: FDA, date: April 14, 2025
- [483 - SRI Krishna Pharmaceuticals Ltd - Unit I - 2023-09-01](https://www.keypedia.com/records/483/sri-krishna-pharmaceuticals-ltd-unit-i/6e5e2af0-2250-4586-b754-3b07e8f471ec) — source: FDA, date: September 1, 2023
- [FDA Inspection 1219348 - SRI Krishna Pharmaceuticals Ltd - Unit I - 2023-09-01](https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-ltd-unit-i/abc43a24-1b12-4cba-9d71-bca900b6cd7d) — classification: Official Action Indicated (OAI), source: FDA, date: September 1, 2023
- [FDA Inspection 928508 - SRI Krishna Pharmaceuticals Ltd - Unit I - 2015-05-15](https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-ltd-unit-i/1d156bf0-5ebd-475a-84e2-9dd4cc4b185e) — classification: No Action Indicated (NAI), source: FDA, date: May 15, 2015
- [FDA Inspection 757323 - SRI Krishna Pharmaceuticals Ltd - Unit I - 2011-11-17](https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-ltd-unit-i/91b33ce2-e52c-4ab8-a989-710c248c8070) — classification: No Action Indicated (NAI), source: FDA, date: November 17, 2011

## Related Companies

- [Smithfield Bioscience Inc](https://www.keypedia.com/companies/smithfield-bioscience-inc/f87613b8-a59a-4a6d-b412-9f2b145f397b)
- [Grant Industries,  Inc.](https://www.keypedia.com/companies/grant-industries-inc/bf60053c-0aa3-4217-b068-ef8b06b6bd27)
- [Tayca Corporation](https://www.keypedia.com/companies/tayca-corporation/46216ddd-c2d8-492b-bbc2-7011e93a98bf)
- [Pharmazell (India) Private Ltd](https://www.keypedia.com/companies/pharmazell-india-private-ltd/1a60e2bc-b058-468d-b52f-ba85d9f757d2)
- [Novo Nordisk US Bio Production Inc.](https://www.keypedia.com/companies/novo-nordisk-us-bio-production-inc/08f5214b-4db0-4d94-86ee-4ba9c3c28ea2)
- [CTX Lifesciences Private Ltd.](https://www.keypedia.com/companies/ctx-lifesciences-private-ltd/cbf6df36-d316-40a9-891a-10cbbb4e757f)
- [Zhejiang Haisen Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-haisen-pharmaceutical-co-ltd/2d2c27d1-770f-4367-a180-92298e925ab8)
- [Shenzhen Oriental Pharmaceutical Co Ltd](https://www.keypedia.com/companies/shenzhen-oriental-pharmaceutical-co-ltd/71227651-964f-4f33-a24b-5c0b0f6c92a0)
- [Union Carbide Corporation](https://www.keypedia.com/companies/union-carbide-corporation/fa8b4f2e-e47c-4e36-995c-107388af99a5)
- [Hetero Drugs Ltd. - Unit 1](https://www.keypedia.com/companies/hetero-drugs-ltd-unit-1/4c15935a-9ff7-4f66-b649-3d78aa3e9753)

## Related Officers

- [Consumer Safety Officer - Dedicated Foreign Drug Cadre](https://www.keypedia.com/people/tamil-arasu/94efc491-7d9f-4221-a1ee-69a925acb1c3)
- [Pratik S. Upadhyay](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)
- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)
- [Investigator](https://www.keypedia.com/people/clinton-j-lott/ac4c7d18-13fd-4b1b-b2a1-06794c9960c7)
- [Arsen Kareptyan](https://www.keypedia.com/people/arsen-kareptyan/fc485c1b-c4e0-469a-9701-c8a5206ebf0d)
- [Arsen Karepetyan](https://www.keypedia.com/people/arsen-karepetyan/45755c9a-11ee-45b4-b152-ad409804028b)